Skip to main content

A Model-Robust G-Computation Method for Analyzing Hybrid Control Studies Without Assuming Exchangeability

Journal
Statistics in medicine (Q1)
Published
1 October 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Zhiwei Zhang, Peisong Han, Wei Zhang
PMID
42802529
DOI
10.1002/sim.70754

Why clinicians should know about it

  • Picked for Health Informatics (top studies of the week, 4 October 2026): High-quality evidence in a top journal

Abstract

There is growing interest in a hybrid control design for treatment evaluation, where a randomized controlled trial is augmented with external control data from a previous trial or a real-world data source. The hybrid control design has the potential to improve efficiency but also carries the risk of introducing bias. The potential bias in a hybrid control study can be mitigated by adjusting for baseline covariates that are related to the control outcome. Existing methods that serve this purpose commonly assume that the internal and external control outcomes are exchangeable upon conditioning on a set of measured covariates. Possible violations of the exchangeability assumption can be addressed using a g-computation method with variable selection under a correctly specified outcome regression model. In this article, we point out that a particular version of this g-computation method is protected against misspecification of the outcome regression model. This observation leads to a model-robust g-computation method that is remarkably simple and easy to implement, consistent and asymptotically normal under minimal assumptions, and able to improve efficiency by exploiting similarities between the internal and external control groups. The method is evaluated in a simulation study and illustrated using real data from HIV treatment trials.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.